85H-28730-86202
4 vaccinations
8 coded responses
45 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 200 / DC
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Pyrexia — Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessFree text: Tenderness in axial lymph nodes on injection side. Peak fever last night (after v-safe check-in time) with reading of 103.3° F.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swelling of lymph nodes in armpit on injection sideMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Mild swelling in armpit lymph nodes on injection armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-10-02
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Significant swelling of lymph nodes in neck and armpit of injection sideMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Redness, Swelling, Itching · Fever · Chills, Headache · Be unable to do your normal daily activitiesFree text: Significant swelling of lymph nodes in neck and armpit of injection sideMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · HeadacheFree text: Significant swelling of lymph nodes on the side of the injectionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Mild swelling of lymph nodes on injection sideMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2022-01-01
- 2022-04-02
- 2022-10-02
-
2022-10-19
Dose 4 — Pfizer-BioNTech
-
2022-10-19
Health check-in — day 0, dose 4Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2022-10-20
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-10-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Swelling · Fatigue or tirednessAdult check-in
-
2022-10-22
Survey response — days 1–6 daily, dose 4MedDRA: Pre-existing disease, Rash — Feeling: Fair · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Flair up of chronic idiopathic skin rash. Rash pre- dates this shot, but recent exacerbation coincides.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-23
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2022-11-30
- 2023-01-18
- 2023-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-10-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Tenderness in axial lymph nodes on injection side. Peak fever last night (after v-safe check-in time) with reading of 103.3° F.
Systemic reaction (other): Swelling of lymph nodes in armpit on injection side
Systemic reaction (other): Mild swelling in armpit lymph nodes on injection arm
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Significant swelling of lymph nodes in neck and armpit of injection side
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Significant swelling of lymph nodes in neck and armpit of injection side
Systemic reaction (other): Significant swelling of lymph nodes on the side of the injection
Systemic reaction (other): Mild swelling of lymph nodes on injection side
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Flair up of chronic idiopathic skin rash. Rash pre- dates this shot, but recent exacerbation coincides.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release